NovoCure (NVCR) Interest Coverage Ratio (QoQ) (2014 - 2022)
NovoCure (NVCR) Interest Coverage Ratio (QoQ) (2014 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | NovoCure | 1.63 Bn | 1.20 Bn | 135.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -1,910.71% |
| Mar 31, 2022 | 95.62% |
| Dec 31, 2021 | -149.19% |
| Sep 30, 2021 | 66.99% |
| Jun 30, 2021 | -39,228.54% |
| Mar 31, 2021 | -100.90% |
| Dec 31, 2020 | -1.86% |
| Sep 30, 2020 | 48.02% |
| Jun 30, 2020 | 283.28% |
| Mar 31, 2020 | -1,685.57% |
| Dec 31, 2019 | -94.19% |
| Sep 30, 2019 | 56.31% |
| Jun 30, 2019 | 137.41% |
| Mar 31, 2019 | 35.67% |
| Dec 31, 2018 | -83.28% |
| Sep 30, 2018 | 11.65% |
| Jun 30, 2018 | 5.17% |
| Mar 31, 2018 | -38.20% |
| Dec 31, 2017 | 31.15% |
| Sep 30, 2017 | 61.41% |